Article ; Online: Simvastatin Attenuates Hippocampal MMP-9 Expression in the Streptozotocin-Induced Cognitive Impairment
2018 Volume 23, Issue 4, Page(s) 262–271
Abstract: Background: Matrix metalloproteinase-9 (MMP-9) expression has been implicated in molecular mechanisms of neurodegenerative disorders, and its abnormal level has been reported in Alzheimer’s disease (AD). Some protective mechanisms of statins against ... ...
Abstract | Background: Matrix metalloproteinase-9 (MMP-9) expression has been implicated in molecular mechanisms of neurodegenerative disorders, and its abnormal level has been reported in Alzheimer’s disease (AD). Some protective mechanisms of statins against neurodegeneration might be mediated by the inhibition of MMP-9 expression. Here, we investigated the effect of simvastatin on the hippocampal MMP-9 expression in the context of AD. Methods: We examined the influence of three-week simvastatin (5 mg/kg) administration on hippocampal MMP-9 expression in a rat model of cognitive decline induced by streptozotocin (STZ). Spatial long-term memory and MMP-9 expression were assessed by Morris water maze (MWM) test and quantitative polymerase chain reaction, respectively. Results: The results showed a decline in the learning and memory in STZ group when compared with the control group. The MMP-9 up-regulated (1.41 ± 0.2 vs. 0.980 ± 0.02, p < 0.05), and cresyl violet staining showed hippocampal cell damage in STZ group compared with the control group. Simvastatin prevented the up-regulation of MMP-9 (1.05 ± 0.05 vs. 1.41 ± 0.2, p < 0.05), improved spatial memory impairment and attenuated hippocampal cell damage. Furthermore, we found a negative correlation (r = 0.77) between MMP-9 expression and cognitive function. Conclusion: Our findings suggest that the neuroprotective influence of simvastatin in battle to cognitive impairment is mediated in part by the modulation of MMP-9 expression. The reduction of MMP-9 expression in simvastatin-treated animals is in correlation with the improvement of cognitive functions. Understanding the protective mechanism of simvastatin will shed light on more efficient therapeutic modalities in AD. |
---|---|
MeSH term(s) | Animals ; Cell Shape/drug effects ; Cognitive Dysfunction/chemically induced ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/enzymology ; Cognitive Dysfunction/physiopathology ; Gene Expression Regulation, Enzymologic/drug effects ; Hippocampus/drug effects ; Hippocampus/enzymology ; Hippocampus/physiopathology ; Male ; Matrix Metalloproteinase 9/genetics ; Matrix Metalloproteinase 9/metabolism ; Maze Learning/drug effects ; Memory/drug effects ; Motor Activity/drug effects ; Neurons/drug effects ; Neurons/pathology ; Pyramidal Cells/drug effects ; Pyramidal Cells/metabolism ; Rats, Wistar ; Simvastatin/pharmacology ; Simvastatin/therapeutic use ; Streptozocin |
Chemical Substances | Streptozocin (5W494URQ81) ; Simvastatin (AGG2FN16EV) ; Matrix Metalloproteinase 9 (EC 3.4.24.35) |
Language | English |
Publishing date | 2018-09-16 |
Publishing country | Iran |
Document type | Journal Article |
ZDB-ID | 2489282-8 |
ISSN | 2008-823X ; 1028-852X |
ISSN (online) | 2008-823X |
ISSN | 1028-852X |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6776: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.